<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04544397</url>
  </required_header>
  <id_info>
    <org_study_id>LIGHT-AF</org_study_id>
    <nct_id>NCT04544397</nct_id>
  </id_info>
  <brief_title>Outcomes of Second Generation Laser Balloon Ablation for Atrial Fibrillation</brief_title>
  <acronym>LIGHT-AF</acronym>
  <official_title>Outcomes of Second Generation Laser Balloon Ablation for Atrial Fibrillation Assessed by Continuous Rhythm Monitoring</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Luigi Sacco University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Luigi Sacco University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to collect data on laser ballon (2nd gen) systems for catheter&#xD;
      ablation for AF, in order to determine the safety and the efficacy of this technique.&#xD;
&#xD;
      Moreover, the investigators aim to determine the short and long term outcomes of pulmonary&#xD;
      vein isolation evaluating arrhythmia recurrence, especially using continuous rhythm&#xD;
      monitoring with implantable loop recorders (ILR).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      LIGHT-AF is an observational, multicentric study designed to collect pre-procedural,&#xD;
      procedural and follow-up data of consecutive patients that underwent catheter ablation for AF&#xD;
      with laser ballon (2nd gen system). A number of 3 enrolling centers is estimated with an&#xD;
      overall number of about 100 patients. A minimal follow-up of 3 months is required before&#xD;
      analyzing clinical outcomes. The data analysis will focus on implant outcomes and early, mid&#xD;
      and long-term recurrence of AF, evaluated with intracardiac rhythm monitoring.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">September 28, 2018</start_date>
  <completion_date type="Anticipated">December 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2022</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <target_duration>2 Years</target_duration>
  <primary_outcome>
    <measure>AF recurrences</measure>
    <time_frame>2 years</time_frame>
    <description>Time to first recurrence of symptomatic or asymptomatic atrial tachyarrhythmias</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Arrhythmia burden</measure>
    <time_frame>2 years</time_frame>
    <description>Percentage of overall time in AF</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Redo ablation procedures</measure>
    <time_frame>2 years</time_frame>
    <description>Patients requiring a redo ablation procedure, after the first one</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse events</measure>
    <time_frame>2 years</time_frame>
    <description>Procedural mortality or other adverse events related to the procedure</description>
  </secondary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Atrial Fibrillation</condition>
  <condition>Atrial Fibrillation Paroxysmal</condition>
  <condition>Atrial Fibrillation, Persistent</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Catheter Ablation for AF</intervention_name>
    <description>Pulmonary vein isolation (PVI) is the mainstay goal of atrial fibrillation (AF) ablation procedures, especially in paroxysmal AF (PAF), and is recommended during all AF ablation procedures. PVI can be obtained with different techniques, using 3D-mapping systems guiding point-by-point radiofrequency (RF) ablation procedures or balloon-based ablation systems (cryo- or laser balloon), introduced to simplify catheter ablation for AF. In particular, the 2nd generation of visually guided laser balloon ablation system (LB2) makes use of laser energy to achieve PVI, leading to better PV occlusion and isolation compared to the 1st generation.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients &gt;/= 18 years, with paroxysmal or persistent AF, that met the indications provided&#xD;
        by international guidelines to undergo catheter ablation for AF as standard of care.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age &gt;/= 18 years&#xD;
&#xD;
          -  Patients with paroxysmal, persistent or long-standing persistent AF&#xD;
&#xD;
          -  Patients able to provide written informed consent or have informed consent as provided&#xD;
             by a legal representative&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Age &lt; 18 years&#xD;
&#xD;
          -  Patients unable or unwilling to receive oral anticoagulation&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>IRCCS Policlinico San Donato</name>
      <address>
        <city>San Donato Milanese</city>
        <state>Milano</state>
        <zip>20097</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale Luigi Sacco - Polo Universitario</name>
      <address>
        <city>Milan</city>
        <state>Mi</state>
        <zip>20174</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale San Gerardo - ASST Monza</name>
      <address>
        <city>Monza</city>
        <zip>20900</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>September 2, 2020</study_first_submitted>
  <study_first_submitted_qc>September 9, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 10, 2020</study_first_posted>
  <last_update_submitted>September 9, 2020</last_update_submitted>
  <last_update_submitted_qc>September 9, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 10, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Luigi Sacco University Hospital</investigator_affiliation>
    <investigator_full_name>Giovanni B Forleo</investigator_full_name>
    <investigator_title>Section Head Electrophysiology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

